The program also allows patients to meet monthly with a doctor and access an educational curriculum for weight management
That's by design - the goal is to pick up the conversation right where the ad left off, not throw you into something that reads like a completely different document
GLP-1 agonists, a novel class of anti-diabetic drugs, are an integral part of the management of patients with type 2 diabetes (7476)
The reduced appetite makes every calorie count more, and the autoimmune condition places specific demands on dietary composition
Retrieved March 10, 2026, from After adding coverage of GLP-1s for weight loss August 1, 2024, North Carolina Medicaid reversed course to end coverage effective October 1, 2025, due to North Carolina Department of Health and Human Services (DHHS) anticipated shortfalls in state funding prompted by budget disagreements in the North Carolina General Assembly